Synchrotron X-ray fluorescence microscopy of gallium in bladder tissue following gallium maltolate administration during urinary tract infection

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5197-5201

  Ball, Katherine R ^a   Sampieri, Francesca ^a   Chirino, Manuel ^a   Hamilton, Don L ^a   Blyth, Robert I R ^b   Sham, Tsun Kong ^c   Dowling, Patricia M ^a   Thompson, Julie ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b CANADIAN LIGHT SOURCE INC   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM; GALLIUM MALTOLATE; IRON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BLADDER; BLADDER EPITHELIUM; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNCHROTRON; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; X RAY ABSORPTION SPECTROSCOPY; X RAY FLUORESCENCE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CYSTITIS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ESCHERICHIA COLI INFECTIONS; FEMALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; ORGANOMETALLIC COMPOUNDS; PYRONES; SYNCHROTRONS; URINARY BLADDER; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM; X-RAYS;

EID: 84885924520     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00616-13     Document Type: Article

References (37)

1. Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. 2007. Community-onset urinary tract infections: a population-based assessment. Infection 35:150-153.
2. Ball KR, Rubin JE, Chirino-Trejo M, Dowling PM. 2008. Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital, 2002-2007. Can. Vet. J. 49:985-990.
3. Foxman B. 2003. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49:53-70.
4. Low DA, Braaten BA, Ling GV, Johnson DL, Ruby AL. 1988. Isolation and comparison of Escherichia coli strains from canine and human patients with urinary tract infections. Infect. Immun. 56:2601-2609.
5. Kurazono H, Nakano M, Yamamoto S, Ogawa O, Yuri K, Nakata K, Kimura M, Makino S, Nair GB. 2003. Distribution of the usp gene in uropathogenic Escherichia coli isolated from companion animals and correlation with serotypes and size-variations of the pathogenicity island. Microbiol. Immunol. 47:797-802.
6. Johnson JR, Clabots C. 2006. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin. Infect. Dis. 43:e101-e108.
7. Gupta K, Hooton TM, Wobbe CL, Stamm WE. 1999. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int. J. Antimicrob. Agents 11:305-308.
8. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. 2002. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46:2540-2545.
9. Nys S, Terporten PH, Hoogkamp-Korstanje JA, Stobberingh EE. 2008. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). J. Antimicrob. Chemother. 62:126-132.
10. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-20.
11. Schilling JD, Lorenz RG, Hultgren SJ. 2002. Effect of trimethoprimsulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 70: 7042-7049.
12. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54:1855-1863.
13. Emody L, Kerenyi M, Nagy G. 2003. Virulence factors of uropathogenic Escherichia coli. Int. J. Antimicrob. Agents 22(Suppl 2):29 -33.
14. Bernstein LR. 1998. Mechanisms of therapeutic activity for gallium. Pharmacol. Rev. 50:665-682.
15. Weiner RE. 1996. The mechanism of 67Ga localization in malignant disease. Nucl. Med. Biol. 23:745-751.
16. Emery T. 1986. Exchange of iron by gallium in siderophores. Biochemistry 25:4629-4633.
17. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. 2007. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117: 877-888.
18. Olakanmi O, Britigan BE, Schlesinger LS. 2000. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68:5619-5627.
19. Bernstein LR, Tanner T, Godfrey C, Noll B. 2000. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Met. Based Drugs 7:33-47.
20. Berry JP, Poupon MF, Galle S, Escaig F. 1984. Role of lysosomes in gallium concentration by mammalian tissues. Biol. Cell 51:43-51.
21. Palmer BM, Vogt S, Chen Z, Lachapelle RR, Lewinter MM. 2006. Intracellular distributions of essential elements in cardiomyocytes. J. Struct. Biol. 155:12-21.
22. Rao DV, Swapna M, Cesareo R, Brunetti A, Akatsuka T, Yuasa T, Takeda T, Tromba G, Gigante GE. 2009. Investigation of the distribution of elements in snail shell with the use of synchrotron-based, micro-beam X-ray fluorescence spectrometry. J. Trace Elem. Med. Biol. 23:251-257.
23. Ishihara R, Ide-Ektessabi A, Ikeda K, Mizuno Y, Fujisawa S, Takeuchi T, Ohta T. 2002. Investigation of cellular metallic elements in single neurons of human brain tissues. Neuroreport 13:1817-1820.
24. Wagner D, Maser J, Moric I, Boechat N, Vogt S, Gicquel B, Lai B, Reyrat JM, Bermudez L. 2005. Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology 151: 323-332.
25. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497.
26. Heald S, Cross J, Brewe D, Gordon R. 2007. The PNC/XOR X-ray microprobe station at APS sector 20. Nucl. Instrum. Methods Phys. Res. A 582:215-217.
27. Abràmoff MD, Magalhães PJ, Ram SJ. 2004. Image processing with imageJ. Biophotonics Int. 11:36-41.
28. Ravel B, Newville M. 2005. ATHENA, ARTEMIS, HEPHAESTUS: data analysis for X-ray absorption spectroscopy using IFEFFIT. J. Synchrotron Radiat. 12:537-541.
29. Harrington JR, Martens RJ, Cohen ND, Bernstein LR. 2006. Antimicrobial activity of gallium against virulent Rhodococcus equi in vitro and in vivo. J. Vet. Pharmacol. Ther. 29:121-127.
30. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews NC. 2005. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 115:1258-1266.
31. Wang J, Pantopoulos K. 2011. Regulation of cellular iron metabolism. Biochem. J. 434:365-381.
32. MacKenzie EL, Iwasaki K, Tsuji Y. 2008. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10:997-1030.
33. Matsuyama S, Shimura M, Mirnura H, Fujii M, Yumoto H, Sano Y, Yabashi M, Nishino Y, Tamasaku K, Ishikawa T, Yamauchi K. 2009. Trace element mapping of a single cell using a hard x-ray nanobeam focused by a Kirkpatrick-Baez mirror system. X Ray Spectrom. 38:89-94.
34. Meitzner GD, Iglesia E, Baumgartner JE, Huang ES. 1993. The chemical-state of gallium in working alkane dehydrocyclodimerization catalysts -in situ gallium K-edge X-ray absorption-spectroscopy. J. Catal. 140:209-225.
35. Faro AC, Eon JG, Nogueira L, da Silva RF, Rodrigues VD. 2008. XAFS study of H-ZSM5 catalysts modified with gallium. Catal. Today 133:913-918.
36. DeLeon K, Balldin F, Watters C, Hamood A, Griswold J, Sreedharan S, Rumbaugh KP. 2009. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob. Agents Chemother. 53:1331-1337.
37. Collery P, Keppler B, Madoulet C, Desoize B. 2002. Gallium in cancer treatment. Crit. Rev. Oncol. Hematol. 42:283-296.